Showing 1,381 - 1,400 results of 4,368 for search '(( significant decrease decrease ) OR ( significant clinical decrease ))~', query time: 0.43s Refine Results
  1. 1381

    Table 1_Real-world first-line serplulimab therapy for advanced esophageal cancer: effectiveness, safety, and clinical implications.docx by Fei Yan (128878)

    Published 2025
    “…Objective<p>The phase III ASTRUM-007 trial demonstrated significant clinical benefit in patients with PD-L1-positive esophageal squamous cell carcinoma (ESCC) treated with first-line serplulimab plus chemotherapy. …”
  2. 1382

    Data Sheet 1_Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.docx by Yitan Li (1449217)

    Published 2024
    “…Silencing bla<sub>KPC</sub> expression significantly decreased the CZA MIC in resistant subpopulations with high bla<sub>KPC</sub> expression and hindered the emergence of CZA heteroresistance in their parental strains. …”
  3. 1383

    Image 1_Clinical study of PLA2R epitope spreading for predicting proteinuria remission in primary membranous nephropathy.pdf by Xueyang Cheng (22473883)

    Published 2025
    “…In the RTX group, epitope spreading significantly decreased at M6 (P = 0.004), and four patients (22.2%) with no clinical remission were ARA-positive. …”
  4. 1384

    Supplementary file 3_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  5. 1385

    Supplementary file 2_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  6. 1386

    Supplementary file 6_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  7. 1387

    Supplementary file 1_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  8. 1388

    Supplementary file 5_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  9. 1389

    Supplementary file 4_Development and preliminary clinical feasibility of a Delphi-based aerobic exercise prescription for children with asthma.docx by Ying Zhang (40767)

    Published 2025
    “…Objective<p>This study aims to develop a clinically applicable aerobic exercise prescription for children with asthma using a two-round Delphi consensus process and to preliminarily evaluate its feasibility and safety of this prescription in a pre–post pilot study. …”
  10. 1390

    Table1_Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection.pdf by Haonan Wang (667218)

    Published 2024
    “…</p>Conclusion<p>ARC is a phenomenon significantly underestimated in pediatric patients with severe sepsis associated with MRSA infection, which can affect 74.9% of these patients and affects the process of anti-infection treatment and clinical outcomes. …”
  11. 1391

    Table1_Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection.pdf by Haonan Wang (667218)

    Published 2024
    “…</p>Conclusion<p>ARC is a phenomenon significantly underestimated in pediatric patients with severe sepsis associated with MRSA infection, which can affect 74.9% of these patients and affects the process of anti-infection treatment and clinical outcomes. …”
  12. 1392

    Image1_Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection.pdf by Haonan Wang (667218)

    Published 2024
    “…</p>Conclusion<p>ARC is a phenomenon significantly underestimated in pediatric patients with severe sepsis associated with MRSA infection, which can affect 74.9% of these patients and affects the process of anti-infection treatment and clinical outcomes. …”
  13. 1393

    Image1_Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection.pdf by Haonan Wang (667218)

    Published 2024
    “…</p>Conclusion<p>ARC is a phenomenon significantly underestimated in pediatric patients with severe sepsis associated with MRSA infection, which can affect 74.9% of these patients and affects the process of anti-infection treatment and clinical outcomes. …”
  14. 1394

    Characteristics of the study participants. by Michał Wendt (17601180)

    Published 2025
    “…Pain intensity decreased significantly in the experimental group for maximum pain during the last week and during sitting (>30 min) (p ≤ 0.01; r = 0.79–0.90). …”
  15. 1395
  16. 1396

    Table 1_Efficiency analysis of primary health care resources: DEA and Tobit regression evidence from village clinics in Jiangsu Province.docx by Wei Jiang (14986)

    Published 2025
    “…From 2015 to 2022, the average Malmquist Productivity Index was 0.96, with a significant decline of 11.6% in 2021–2022, primarily due to a 6.8% decrease in technological change. …”
  17. 1397

    Table 2_Efficiency analysis of primary health care resources: DEA and Tobit regression evidence from village clinics in Jiangsu Province.docx by Wei Jiang (14986)

    Published 2025
    “…From 2015 to 2022, the average Malmquist Productivity Index was 0.96, with a significant decline of 11.6% in 2021–2022, primarily due to a 6.8% decrease in technological change. …”
  18. 1398

    Table 3_Efficiency analysis of primary health care resources: DEA and Tobit regression evidence from village clinics in Jiangsu Province.docx by Wei Jiang (14986)

    Published 2025
    “…From 2015 to 2022, the average Malmquist Productivity Index was 0.96, with a significant decline of 11.6% in 2021–2022, primarily due to a 6.8% decrease in technological change. …”
  19. 1399

    Dataset for Generative artificial intelligence models in clinical infectiousdisease consultations: a cross-sectional analysis among specialists andresident trainees by Kwan Yeung Edwin Chiu (20718422)

    Published 2025
    “…Specialists consistently rated the responses more favorably than resident trainees, highlighting a discrepancy in clinical judgment. Cost analysis revealed decreasing operating expenses over time, but model performance was not directly correlated with cost. …”
  20. 1400

    Image 1_Yacon root is a functional food beneficial for human health: a meta-analysis of clinical trials.pdf by Ling-Hui Pan (9341084)

    Published 2025
    “…The pooled results showed that YR significantly reduced BMI [SMD = −0.81, 95%CI (−1.54, −0.08)], decreased stool pH [SMD = −1.12, 95%CI (−1.61, −0.62)], softened stools [SMD = 0.94, 95%CI (0.08, 1.80)], facilitated defecation [SMD = 4.03, 95% CI (0.54, 7.52)], improved fiber consumption patterns [SMD = 0.58, 95%CI (0.18, −0.99)]. …”